检索结果 - Sanjeev Pathak
- Showing 1 - 8 results of 8
-
1
-
2
-
3
-
4
Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia 由 William Martin, Christoph U. Correll, Peter J. Weiden, Ying Jiang, Sanjeev Pathak, Lauren DiPetrillo, Bernard L. Silverman, Elliot Ehrich
出版 2019Artigo -
5
Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies 由 Maurizio Fava, Michael E. Thase, Madhukar H. Trivedi, Elliot Ehrich, William Martin, Aslı Memişoğlu, Narinder Nangia, Arielle D. Stanford, Miao Yu, Sanjeev Pathak
出版 2018Artigo -
6
Treatment for Adolescents With Depression Study (TADS) 由 Graham J. Emslie, Christopher J. Kratochvil, Benedetto Vitiello, Susan G. Silva, Taryn L. Mayes, Steven McNulty, Elizabeth B. Weller, Bruce Waslick, Charles D. Casat, John T. Walkup, Sanjeev Pathak, Paul Rohde, Kelly Posner, John S. March
出版 2006Artigo -
7
Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study 由 Gerard Sanacora, Michael Johnson, Arif Khan, Sarah Atkinson, R. Riesenberg, Juan Schronen, Michael A. Burke, John Zajecka, L Barra, Hong-Lin Su, Joel A. Posener, Khanh Bui, Michael C. Quirk, Timothy M. Piser, Sanjay J. Mathew, Sanjeev Pathak
出版 2016Artigo -
8
An Exploratory Analysis of the Impact of Family Functioning on Treatment for Depression in Adolescents 由 Norah C. Feeny, Susan G. Silva, Mark A. Reinecke, Steven McNulty, Robert L. Findling, Paul Rohde, John F. Curry, Golda S. Ginsburg, Christopher J. Kratochvil, Sanjeev Pathak, Diane May, Betsy D. Kennard, Anne D. Simons, Karen C. Wells, Michele Robins, David Rosenberg, John S. March
出版 2009Artigo
相关主题
Alternative medicine
Internal medicine
Medicine
Pathology
Placebo
Psychology
Psychiatry
Anesthesia
Depression (economics)
Economics
Macroeconomics
Randomized controlled trial
Receptor
Antidepressant
Clinical endpoint
Schizophrenia (object-oriented programming)
Adjunctive treatment
Adverse effect
Antipsychotic
Hippocampus
Major depressive disorder
Mood
Opioid
(+)-Naloxone
Amygdala
Antagonist
Anthropology
Anxiety
Atypical antipsychotic
Bipolar I disorder